ES8102126A1 - Procedimiento para la produccion e una composicion sinergis-tica a base de derivados de naftiridina - Google Patents

Procedimiento para la produccion e una composicion sinergis-tica a base de derivados de naftiridina

Info

Publication number
ES8102126A1
ES8102126A1 ES487881A ES487881A ES8102126A1 ES 8102126 A1 ES8102126 A1 ES 8102126A1 ES 487881 A ES487881 A ES 487881A ES 487881 A ES487881 A ES 487881A ES 8102126 A1 ES8102126 A1 ES 8102126A1
Authority
ES
Spain
Prior art keywords
carbon atoms
hydrogen
chlorine
alkoxy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES487881A
Other languages
English (en)
Other versions
ES487881A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8102126A1 publication Critical patent/ES8102126A1/es
Publication of ES487881A0 publication Critical patent/ES487881A0/es
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PRODUCCION DE UNA COMPOSICION SINERGISTICA A BASE DE DERIVADOS DE NAFTIRIDINA DE FORMULA (I), DONDE R1, R2, R3 Y R4 PUEDEN SER DIVERSOS TIPOS DE RADICALES, Y UN AGENTE BLOQUEADOR DE -BETA-ADRENOCEPTORES. SE CARACTERIZA PORQUE SE EFECTUA LA COMBINACION FISICOQUIMICA SINERGISTICA EN UNA PROPOCIONCOMPENIA ENTRE 500:1 Y 1:1 EN PESO. ESTE COMPUESTO SIRVE PARA OBTENER COMPOSICIONES FARMACEUTICAS. *FORMULA*
ES487881A 1979-01-22 1980-01-21 Procedimiento para la produccion e una composicion sinergis-tica a base de derivados de naftiridina Granted ES487881A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7902147 1979-01-22

Publications (2)

Publication Number Publication Date
ES8102126A1 true ES8102126A1 (es) 1980-12-16
ES487881A0 ES487881A0 (es) 1980-12-16

Family

ID=10502644

Family Applications (1)

Application Number Title Priority Date Filing Date
ES487881A Granted ES487881A0 (es) 1979-01-22 1980-01-21 Procedimiento para la produccion e una composicion sinergis-tica a base de derivados de naftiridina

Country Status (12)

Country Link
AU (1) AU5478180A (es)
BE (1) BE880455A (es)
DE (1) DE3001016A1 (es)
ES (1) ES487881A0 (es)
FR (1) FR2446636A1 (es)
GB (1) GB2040682A (es)
IE (1) IE800115L (es)
IL (1) IL59176A0 (es)
NL (1) NL8000332A (es)
PT (1) PT70715A (es)
SE (1) SE8000268L (es)
ZA (1) ZA80369B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3423003A1 (de) * 1984-06-22 1986-01-02 Beiersdorf Ag, 2000 Hamburg Benzo(c)(1,8)naphthyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
US4652567A (en) * 1985-03-13 1987-03-24 Hoechst-Roussel Pharmaceuticals Inc. Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1361441A (en) * 1970-05-13 1974-07-24 Sandoz Ltd Benzonaphthyridine derivatives
JPS5585519A (en) * 1978-12-11 1980-06-27 Sandoz Ag Novel use of benzo*c**1*6*naphthyridine and medical composition containing same and betaablocking agent

Also Published As

Publication number Publication date
IE800115L (en) 1980-07-22
FR2446636A1 (fr) 1980-08-14
NL8000332A (nl) 1980-07-24
BE880455A (fr) 1980-06-06
IL59176A0 (en) 1980-05-30
DE3001016A1 (de) 1980-07-31
SE8000268L (sv) 1980-07-23
ZA80369B (en) 1981-08-26
PT70715A (en) 1980-02-01
GB2040682A (en) 1980-09-03
ES487881A0 (es) 1980-12-16
AU5478180A (en) 1980-07-31

Similar Documents

Publication Publication Date Title
DE3587568D1 (de) Diazepine enthaltende pharmazeutische Zusammensetzungen mit Plättchen aktivierender Faktor (PAF)-antagonistischer Wirkung.
ES8705837A1 (es) Un procedimiento para la preparacion de derivados de naftaleno.
DE69505968T2 (de) Azolidindion-derivate und ihre anwendung als antihyperglykämika
NZ330973A (en) Azolobenzazepine derivatives as neurologically active agents
EP0632031A4 (es)
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
SE8503415L (sv) Nya isoindolinylalkylpiperaziner och farmaceutiska kompositioner innehallande desamma
ES466143A1 (es) Un procedimiento de preparacion de nuevas imidazoquinoleinas
SE8500107L (sv) Nya 8-alfa-acylaminoergoline
ZA858418B (en) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazoline-3-one compounds and methods for the preparation thereof,intermediates for use in the preparation of said compounds and medicaments containing said compounds
AU554959B2 (en) Triazolo(4,3-a) quinazolin-5-ones
ES8102126A1 (es) Procedimiento para la produccion e una composicion sinergis-tica a base de derivados de naftiridina
MY104955A (en) Pyrroloquinoline and pyrrolophemothiazine carboxamides and related compounds.
ATE88467T1 (de) Pharmakologisch aktive alkylol-derivate.
DE3769451D1 (de) Indan-derivate, verfahren zu ihrer herstellung und die erhaltenen zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
ES8800220A1 (es) Procedimiento para la produccion de 8-alfa-acilamino-ergolinas.
IL67564A (en) 7-heteroaryl-(1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them
SE7905051L (sv) Nya sulfonamider
ES433957A1 (es) Un procedimiento de preparacion de nuevas fenotiazinas.
ES2009283A6 (es) Procedimiento para preparar nuevos aminoacilatos de glicerol-acetal.
ES479005A1 (es) Un procedimiento para obtener derivados de quinazolina.
RU92016560A (ru) Замещенные бензоимидазолы, фармацевтическая композиция, способ ингибирования или лечения и способ их получения и применение